学会概要

Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Outsourcing Manufacturing of Biopharmaceuticals
• Biopharmaceutical Raw Materials throughout the Product Lifecycle

Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:

• Antibody Development & Production
• Recombinant Protein & Complex Biologic Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

近几年发生起因于外来性物质的事故，故监督机关强化监视，以供应链的所有部分来检测原料、细胞培养的制程和设施是否遭病毒污染，然后作预防与改善的新技术及减轻风险策略的必要性益发高涨。

学会采用的话题

• 因应单株抗体、蛋白质及疫苗产品的风险之基本对策和策略
• 为了建构有效的病毒屏障之新策略和技术：查出未知的外来性物质之方法
• 奈米过滤和前置过滤：与新技术、验证和法规有关的辅导手册
• 制止病毒和精制超高纯度病毒：制程和法规的影响
• 针对污染的个案研究和设施保护策略：教训和矫正措施
• 细胞银行、细胞株、细胞基质、培养基：检查原料的重要性

特别演讲

MMV Contamination: Detection, Root Cause Determination, and Corrective Actions
Mark D. Moody, Ph.D.
Vice President of Analytical Services
Merrimack Pharmaceuticals

Ways to Maximize Throughput in Virus Filtration
Jerome Bill Jr.
Engineer II, Purification Development
Genentech, Inc.

Applying a Risk-based Product Protection Strategy to a New Mammalian Cell Culture Bioprocessing Facility
Marie Murphy, Ph.D.
Microbiologist, Biotechnology Operations
Eli Lilly, Ireland

Testing Raw Materials for Adventitious Agents Prior to Use in Manufacturing
Sridhar Pennathur, Ph.D.
Senior Director, Biosafety Testing, Department of Quality Control
MedImmune, Inc.